BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28390982)

  • 1. A Retrospective Study of Central Nervous System Invasive Fungal Disease after Allogeneic Stem Cell Transplantation: Risk Factors, Clinical Characteristics, and Outcomes.
    Sun YQ; Liu ZY; Huang XJ; Yan CH; Xu LP; Zhang XH; Liu KY; Wang Y
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1158-1164. PubMed ID: 28390982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.
    Yong MK; Ananda-Rajah M; Cameron PU; Morrissey CO; Spencer A; Ritchie D; Cheng AC; Lewin SR; Slavin M
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1961-1967. PubMed ID: 28797778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal agents for secondary prophylaxis based on response to initial antifungal therapy in allogeneic hematopoietic stem cell transplant recipients with prior pulmonary aspergillosis.
    Liu Q; Lin R; Sun J; Xiao Y; Nie D; Zhang Y; Huang F; Fan Z; Zhou H; Jiang Q; Zhang F; Zhai X; Xu D; Wei Y; Song J; Li Y; Feng R
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1198-203. PubMed ID: 24769013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
    Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
    Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
    Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
    Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion.
    Zhao J; Zu Y; Han L; Zhang Y; Gui R; Yu F; Li Z; Zhao H; Fang B; Lin Q; Zhou J; Song Y
    Bone Marrow Transplant; 2019 Jun; 54(6):821-827. PubMed ID: 30518982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.
    Lounder DT; Khandelwal P; Chandra S; Jordan MB; Kumar AR; Grimley MS; Davies SM; Bleesing JJ; Marsh RA
    Biol Blood Marrow Transplant; 2017 May; 23(5):857-860. PubMed ID: 28219834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
    Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.
    Liu M; Li Y; Zhang Y; Zhao X; Zhai B; Zhang Q; Wang L; Zhao Y; Li H; Wang Q; Gao C; Huang W; Yu L
    PLoS One; 2014; 9(12):e115461. PubMed ID: 25531544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
    Rodríguez-Veiga R; Montesinos P; García E; Boluda B; Rojas R; Serrano J; Martínez-Cuadrón D; Martín C; Sanz J; Tabares S; Piñana JL; Lorenzo I; Montoro J; Salavert M; Pemán J; Jarque I; Solves P; Sanz GF; Torres A; Sanz MA
    Mycoses; 2019 May; 62(5):418-427. PubMed ID: 30633829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Hamdi A; Mawad R; Bassett R; di Stasi A; Ferro R; Afrough A; Ram R; Dabaja B; Rondon G; Champlin R; Sandmaier BM; Doney K; Bar M; Kebriaei P
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1767-71. PubMed ID: 25017763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
    Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
    Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.
    Omer AK; Ziakas PD; Anagnostou T; Coughlin E; Kourkoumpetis T; McAfee SL; Dey BR; Attar E; Chen YB; Spitzer TR; Mylonakis E; Ballen KK
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1190-6. PubMed ID: 23747459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
    Ikegawa S; Doki N; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Pathol Oncol Res; 2017 Apr; 23(2):433-437. PubMed ID: 28004352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Chaudhary RK; Dhakal P; Aryal A; Bhatt VR
    Future Oncol; 2017 Oct; 13(25):2297-2312. PubMed ID: 28984145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
    Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
    Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical investigation of reduced-dose voriconazole on primary prevention in invasive fungal disease after allogeneic hematopoietic stem cell transplantation].
    Qiu Z; Ren H; Cen X; Ou J; Xu W; Wang M; Wang L; Dong Y; Li Y; Liu W; Sun Y; Liang Z; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):577-80. PubMed ID: 25052595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
    Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Girmenia C; Raiola AM; Piciocchi A; Algarotti A; Stanzani M; Cudillo L; Pecoraro C; Guidi S; Iori AP; Montante B; Chiusolo P; Lanino E; Carella AM; Zucchetti E; Bruno B; Irrera G; Patriarca F; Baronciani D; Musso M; Prete A; Risitano AM; Russo D; Mordini N; Pastore D; Vacca A; Onida F; Falcioni S; Pisapia G; Milone G; Vallisa D; Olivieri A; Bonini A; Castagnola E; Sica S; Majolino I; Bosi A; Busca A; Arcese W; Bandini G; Bacigalupo A; Rambaldi A; Locasciulli A
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.